
Advances in life sciences are benefitting healthcare interventions and productivity by incorporating innovative technology. Moreover, with government spending and biotech being defensive.
As the industry shows solid potential, fundamentally strong biotech stocks Amicus Therapeutics, Inc. (FOLD), Corcept Therapeutics Incorporated (CORT), and Harmony Biosciences Holdings, Inc. (HRMY) might be solid buys.